MetLife Investment Management’s Microvast MVST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$144K Buy
123,226
+21,004
+21% +$32.4K ﹤0.01% 2596
2026
Q1
$153K Sell
102,222
-4,922
-5% -$11.9K ﹤0.01% 2346
2025
Q4
$300K Sell
107,144
-13,932
-12% -$58.2K ﹤0.01% 2067
2025
Q3
$466K Hold
121,076
﹤0.01% 1841
2025
Q2
$440K Buy
+121,076
New +$354K ﹤0.01% 1737
2024
Q2
Sell
-124,331
Closed -$104K 2908
2024
Q1
$104K Buy
124,331
+3,764
+3% +$3.36K ﹤0.01% 2515
2023
Q4
$169K Buy
120,567
+67,512
+127% +$90.6K ﹤0.01% 2332
2023
Q3
$100K Sell
53,055
-11,911
-18% -$25.5K ﹤0.01% 2573
2023
Q2
$104K Hold
64,966
﹤0.01% 2657
2023
Q1
$80.6K Sell
64,966
-29,690
-31% -$43.1K ﹤0.01% 2639
2022
Q4
$145K Hold
94,656
﹤0.01% 2431
2022
Q3
$171K Hold
94,656
﹤0.01% 2399
2022
Q2
$210K Buy
+94,656
New +$406K ﹤0.01% 2290

Other funds holding MVST

MetLife Investment Management's MVST Position: Q2 2026 in Review

MetLife Investment Management increased its Microvast (MVST) stake by 21% in Q2 2026, buying an estimated $32.4K and bringing the position to 123,226 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #2596.

MetLife Investment Management first reported a position in MVST in Q2 2022 and has held it in 13 quarters since. The position peaked at $466K in Q3 2025. 158 funds tracked by Wall St. Rank hold MVST as of Q2 2026.

  • MetLife Investment Management held 123,226 shares of Microvast worth $144K as of Q2 2026.
  • MetLife Investment Management bought 21,004 Microvast shares in Q2 2026, an estimated $32.4K.
  • Microvast made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2596 holding.
  • MetLife Investment Management first reported a position in Microvast in Q2 2022 and has held it in 13 quarters since.
  • MetLife Investment Management's Microvast position peaked at $466K in Q3 2025.
  • 158 funds tracked by Wall St. Rank held Microvast as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.